Nomograms for predicting pathological response to neoadjuvant treatments in patients with rectal cancer

BACKGROUND: In recent decades, neoadjuvant therapy (NT) has been the standardized treatment for locally advanced rectal cancer (LARC). Approximately 8%-35% of patients with LARC who received NT were reported to have achieved a complete pathological response (pCR). If the pathological response (PR) c...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Dong-Lin, Li, Juan, Yu, Hui-Chuan, Peng, Shao-Yong, Lin, Wei-Da, Wang, Xiao-Lin, Ghoorun, Roshan Ara, Luo, Yan-Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2019
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328965/
https://www.ncbi.nlm.nih.gov/pubmed/30643363
http://dx.doi.org/10.3748/wjg.v25.i1.118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328965/
https://www.ncbi.nlm.nih.gov/pubmed/30643363
http://dx.doi.org/10.3748/wjg.v25.i1.118

Ejemplares similares